212 related articles for article (PubMed ID: 30307465)
41. The Evolving and Future Role of Taxanes in Squamous Cell Carcinomas of the Head and Neck: A Review.
Mody MD; Gill HS; Saba NF
JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):898-905. PubMed ID: 27389786
[TBL] [Abstract][Full Text] [Related]
42. Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinoma.
Sridharan V; Rahman RM; Huang RY; Chau NG; Lorch JH; Uppaluri R; Haddad RI; Hanna GJ; Schoenfeld JD
Oral Oncol; 2018 Oct; 85():29-34. PubMed ID: 30220316
[TBL] [Abstract][Full Text] [Related]
43. Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Cohen EE
J Clin Oncol; 2006 Jun; 24(17):2659-65. PubMed ID: 16763280
[TBL] [Abstract][Full Text] [Related]
44. Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck.
Campbell NP; Hensing TA; Bhayani MK; Shaikh AY; Brockstein BE
Expert Rev Anticancer Ther; 2016 Aug; 16(8):847-58. PubMed ID: 27400139
[TBL] [Abstract][Full Text] [Related]
45. Targeted therapies for squamous cell carcinoma of the head and neck: current knowledge and future directions.
Schmitz S; Ang KK; Vermorken J; Haddad R; Suarez C; Wolf GT; Hamoir M; Machiels JP
Cancer Treat Rev; 2014 Apr; 40(3):390-404. PubMed ID: 24176789
[TBL] [Abstract][Full Text] [Related]
46. Positron Emission Tomography-Computed Tomography Imaging, Genomic Profile, and Survival in Patients With Head and Neck Cancer Receiving Immunotherapy.
Fitzgerald CWR; Valero C; Swartzwelder CE; Morris LGT
JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1119-1120. PubMed ID: 34297796
[TBL] [Abstract][Full Text] [Related]
47. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.
Seiwert TY; Burtness B; Mehra R; Weiss J; Berger R; Eder JP; Heath K; McClanahan T; Lunceford J; Gause C; Cheng JD; Chow LQ
Lancet Oncol; 2016 Jul; 17(7):956-965. PubMed ID: 27247226
[TBL] [Abstract][Full Text] [Related]
48. Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck.
Schmitz S; Machiels JP
Curr Treat Options Oncol; 2016 Jul; 17(7):37. PubMed ID: 27262711
[TBL] [Abstract][Full Text] [Related]
49. Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic review.
Winquist E; Agbassi C; Meyers BM; Yoo J; Chan KKW;
J Otolaryngol Head Neck Surg; 2017 Apr; 46(1):29. PubMed ID: 28376866
[TBL] [Abstract][Full Text] [Related]
50. Baseline caspase activity predicts progression free survival of temsirolimus-treated head neck cancer patients.
John K; Rösner I; Keilholz U; Gauler T; Bantel H; Grünwald V
Eur J Cancer; 2015 Aug; 51(12):1596-602. PubMed ID: 26048456
[TBL] [Abstract][Full Text] [Related]
51. Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN).
Machiels JP; Bossi P; Menis J; Lia M; Fortpied C; Liu Y; Lhommel R; Lemort M; Schmitz S; Canevari S; De Cecco L; Guzzo M; Bianchi R; Quattrone P; Crippa F; Duprez T; Lalami Y; Quiriny M; de Saint Aubain N; Clement PM; Coropciuc R; Hauben E; Licitra LF
Ann Oncol; 2018 Apr; 29(4):985-991. PubMed ID: 29346507
[TBL] [Abstract][Full Text] [Related]
52. Research Progress in Head and Neck Squamous Cell Carcinoma: Best Abstracts of ICHNO 2015.
Economopoulou P; Bourhis J; Psyrri A
Am Soc Clin Oncol Educ Book; 2015; ():e323-8. PubMed ID: 25993192
[TBL] [Abstract][Full Text] [Related]
53. Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).
Tahara M; Kiyota N; Yokota T; Hasegawa Y; Muro K; Takahashi S; Onoe T; Homma A; Taguchi J; Suzuki M; Minato K; Yane K; Ueda S; Hara H; Saijo K; Yamanaka T
Ann Oncol; 2018 Apr; 29(4):1004-1009. PubMed ID: 29408977
[TBL] [Abstract][Full Text] [Related]
54. How Standard Is Second-Line Cetuximab in Recurrent or Metastatic Head and Neck Cancer in 2017?
Szturz P; Seiwert TY; Vermorken JB
J Clin Oncol; 2017 Jul; 35(20):2229-2231. PubMed ID: 28471725
[No Abstract] [Full Text] [Related]
55. Microsatellite instability associated with durable complete response to PD-L1 inhibitor in head and neck squamous cell carcinoma.
Tardy MP; Di Mauro I; Ebran N; Refae S; Bozec A; Benezery K; Peyrade F; Guigay J; Sudaka-Bahadoran A; Badoual C; Pedeutour F; Saada-Bouzid E
Oral Oncol; 2018 May; 80():104-107. PubMed ID: 29631799
[No Abstract] [Full Text] [Related]
56. Genomics and precision surgery for head and neck squamous cell carcinoma.
Galmiche A; Saidak Z; Bouaoud J; Mirghani H; Page C; Dakpé S; Clatot F
Cancer Lett; 2020 Jul; 481():45-54. PubMed ID: 32272147
[TBL] [Abstract][Full Text] [Related]
57. Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.
Giefing M; Wierzbicka M; Szyfter K; Brenner JC; Braakhuis BJ; Brakenhoff RH; Bradford CR; Sorensen JA; Rinaldo A; Rodrigo JP; Takes RP; Ferlito A
Eur J Cancer; 2016 Mar; 55():147-57. PubMed ID: 26851381
[TBL] [Abstract][Full Text] [Related]
58. Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC.
Sun XS; Michel C; Babin E; De Raucourt D; Péchery A; Gherga E; Géry B; Florescu C; Bourhis J; Thariat J
Future Oncol; 2018 Apr; 14(9):877-889. PubMed ID: 29578359
[TBL] [Abstract][Full Text] [Related]
59. Novel Targeted Agents in Head and Neck Squamous Cell Carcinoma.
Isaacsson Velho PH; Castro G; Chung CH
Hematol Oncol Clin North Am; 2015 Dec; 29(6):993-1009. PubMed ID: 26568544
[TBL] [Abstract][Full Text] [Related]
60. Gene expression analysis of head and neck squamous cell carcinoma survival and recurrence.
Zhi X; Lamperska K; Golusinski P; Schork NJ; Luczewski L; Kolenda T; Golusinski W; Masternak MM
Oncotarget; 2015 Jan; 6(1):547-55. PubMed ID: 25575813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
